Rheumatoid Arthritis: Immunohistochemical studies with antibodies against collagen type I, Ii and IIi
Gay, S.; Remberger, K.
Verhandlungen der Deutschen Gesellschaft für Pathologie 1976: 290-291
1976
ISSN/ISBN: 0070-4113 PMID: 799422 Document Number: 99229
Document emailed within 1 workday
Related Documents
Cook, A.D.; Mackay, I.R.; Cicuttini, F.M.; Rowley, M.J. 1997: IgG subclasses of antibodies to type Ii collagen in rheumatoid arthritis differ from those in systemic lupus erythematosus and other connective tissue diseases Journal of Rheumatology 24(11): 2090-2096Kitamura, A. 1994: Study of the effects of a new vitamin D3 derivative on type Ii collagen-induced arthritis in an experimental rat model of rheumatoid arthritis Nihon Seikeigeka Gakkai Zasshi 68(12): 1068-1080
He, X.; Kang, A.H.; Stuart, J.M. 2000: Accumulation of T cells reactive to type II collagen in synovial fluid of patients with rheumatoid arthritis Journal of Rheumatology 27(3): 589-593
Adebajo, A.O.; Williams, R.O.; Williams, D.G.; Hazleman, B.L.; Maini, R.N. 1994: High levels of anti-type II collagen IgG in west African patients with rheumatoid arthritis Journal of Rheumatology 21(12): 2206-2208
Gay, S.; Remberger, K.; Adelmann, B.C. 1975: Immunofluorescence microscopy studies with isolated type-specific antibodies against collagen type I, Ii and IIi in connective tissue diseases Verhandlungen der Deutschen Gesellschaft für Innere Medizin 81: 1183-1185
Cremer, M.A.; Hernandez, A.D.; Townes, A.S.; Stuart, J.M.; Kang, A.H. 1983: Collagen-induced arthritis in rats: antigen-specific suppression of arthritis and immunity by intravenously injected native type Ii collagen Journal of Immunology 131(6): 2995-3000
Kerwar, S.S.; Oronsky, A.L. 1986: Studies on type Ii collagen induced arthritis British Journal of Clinical Practice. Suppl 43: 32-40
Al-Awadhi, A.M.; Olusi, S.O.; al-Zaid, N.S.; Prabha, K.; al-Jarallah, K.H.; Ahmed, A.H.; al-Salem, I.; Sedeqi, H.; Atteyah, Y. 1998: Urine levels of type 1 collagen cross-linked N-telopeptides and deoxypyridinoline correlate with disease activity in rheumatoid arthritis Clinical and Experimental Rheumatology 16(5): 569-572
Riedel, U.; Geiler, G. 1989: Immunohistochemical studies of the synovial membrane in rheumatoid arthritis and osteoarthrosis for quantifying lysozyme and alpha-1-antitrypsin positive mononuclear cells Zeitschrift für Rheumatologie 48(6): 301-306
Sihvonen, S.; Korpela, M.; Mustila, A.; Mustonen, J. 2005: The predictive value of rheumatoid factor isotypes, anti-cyclic citrullinated peptide antibodies, and antineutrophil cytoplasmic antibodies for mortality in patients with rheumatoid arthritis Journal of Rheumatology 32(11): 2089-2094
Awwad, H.M.; Aboukhamis, I.A. 2010: Diagnostic Performances of Anti-Cyclic Citrullinated Peptide Antibodies type IgM, IgA and IgG in Syrian Patients with Rheumatoid Arthritis Clinical Laboratory 56(3-4): 95-102
Gillet, P.; Bannwarth, B.; Charrière, G.; Leroux, P.; Fener, P.; Netter, P.; Hartmann, D.J.; Péré, P.; Gaucher, A. 1989: Studies on type II collagen induced arthritis in rats: an experimental model of peripheral and axial ossifying enthesopathy Journal of Rheumatology 16(6): 721-728
Burrai, I.; Henderson, B.; Knight, S.C.; Staines, N.A. 1985: Suppression of collagen type II-induced arthritis by transfer of lymphoid cells from rats immunized with collagen Clinical and Experimental Immunology 61(2): 368-372
Wang, H.; Feng, Z.; Zhu, J.; Chen, X.; Wu, X.; Li, J. 2017: Zaocys type Ii collagen regulates the balance of Treg/Th17 cells in mice with collagen-induced arthritis Clinical and Experimental Rheumatology 35(3): 452-461
Fukasawa, Y.; Kano, S. 1993: Anti-type Ii collagen antibodies in collagen disease Rinsho Byori. Japanese Journal of Clinical Pathology 41(8): 876-881
Juhl, P.; Thudium, C.S.; Gudmann, N.S.; Karsdal, M.A.; Bay-Jensen, A.-C.; Siebuhr, A.S. 2018: IL-6 receptor inhibition modulates type IIi collagen and C-reactive protein degradation in rheumatoid arthritis patients with an inadequate response to anti-tumour necrosis factor therapy: analysis of connective tissue turnover in the tocilizumab RADIATE study Clinical and Experimental Rheumatology 36(4): 568-574
Punzi, L.; di Maggio, C.; Mazzi, A.; Presacco, D.; Ruffatti, A.; Pellegrini, A.; Todesco, S. 1987: Radiological lesions of the hands in rheumatoid arthritis with rheumatoid factors and antinuclear antibodies Revue du Rhumatisme et des Maladies Osteo-Articulaires 54(7-9): 563-566
Jeng, K.C.; Liu, M.T.; Lan, J.L.; Peng, T.K. 1990: Collagen autoimmunity to rheumatoid arthritis Zhonghua Minguo Wei Sheng Wu Ji Mian Yi Xue Za Zhi 23(3): 239-247
Kuru, O.; Bilgici, A.; Birinci, A.; Ulusoy, H.; Durupinar, B. 2009: Prognostic value of anti-cyclic citrullinated peptide antibodies and rheumatoid factor in patients with rheumatoid arthritis Bratislavske Lekarske Listy 110(10): 650-654
Vischer, T.L.; Jeannet, M. 1986: Lymphocytotoxic antibodies in rheumatoid arthritis: relation to HLA-DR2 and rheumatoid factors Clinical and Experimental Rheumatology 4(2): 139-142